New drug shows promise in leukaemia
December 6th, 2010 - 2:45 pm ICT by IANSLondon, Dec 6 (IANS) A new drug for children who relapse with a type of leukaemia has been found to improve survival rates dramatically.
Called Mitoxantran, the drug has now been shown to increase three-year survival rates to almost 70 percent.
A study in 216 children, funded by Cancer Research UK and Leukaemia & Lymphoma Research, found that Mitoxantran increased three-year survival rates to 69 percent, compared to 45 percent for those on the standard treatment called Idarubicin.
Those on the new drug also experienced fewer side effects, reports the Telegraph.
Every year about 380 children are diagnosed with acute lymphoblastic leukaemia (ALL), a cancer of the white blood cells that progressively hinders the body’s ability to fight infection. Of these, about 40 relapse after initial treatment.
While survival rates for children with ALL have improved significantly in recent years, comparable improvements have not been seen among those who relapse.
Typically, less than half of those who relapsed survived for more than three years,
Cancer Research UK said these results were “so promising that now all children with relapsed ALL are being offered the trial drug Mitoxantrone”.
ALL is the most common type of childhood leukaemia, accounting for around four-fifths (79 percent) of all leukaemias diagnosed in children.
- Breakthrough treatment 'can help kids beat recurring leukaemia' - Dec 04, 2010
- New drug combo may treat newly diagnosed cancer patients - Dec 10, 2010
- Over 40,000 childhood cancer cases in India every year: Experts - Feb 06, 2011
- Two units of umbilical cord blood 'reduce leukemia recurrence risk' - Nov 14, 2009
- Targeted drug therapy shows promise against deadly form of lung cancer - Nov 02, 2010
- Genetic mutations can predict childhood leukaemia relapse - Jan 08, 2009
- Drug company links 'may have compromised cancer study in The Lancet' - Jan 21, 2011
- 'Smart' new drug shows promise in ovarian cancer - Nov 09, 2010
- 'Statins prevent cancer in heart transplant patients' - May 20, 2012
- India witnessing rise in pancreatic cancer, say doctors - Oct 06, 2011
- Drug-chemo combo doubles survival in high-risk childhood leukaemia patients - Oct 07, 2009
- US cancer death rates continue to decline - Mar 29, 2012
- Intestinal stem cells offer clues to colon cancer origin and relapse - Mar 18, 2011
- Cells critical to childhood leukemia identified - Jan 22, 2010
- Arsenic could improve survival for leukaemia patients - Nov 12, 2010
Tags: accounting, cancer research uk, childhood leukaemia, fewer side effects, four fifths, idarubicin, improvements, initial treatment, london, lymphoma, lymphoma research, survival rates, telegraph, white blood cells